
Keywords: α-syn; alpha-synuclein; CNS; central nervous system; PD; Parkinson disease; CX3CR1; fractalkine receptor; CCR2; C-C chemokine receptor type 2; CCL2; C-C chemokine ligand 2; SNpc; substantia nigra pars compacta; GWAS; genome wide association studies; MHCI